Molecular characteristics, such as activation/mutation of HER2/neu, estrogen receptor (ER), progesterone receptor (PR), breast cancer 1/2 (BRCA1/2) gene, and programmed death-ligand 1 (PD-L1), play a crucial role in guiding the management of cancer [5]. This evidence concerns the gene PGR and breast cancer.